UCB's Global Corporate Website
Welcome to UCB in the United States

Dec

02

UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting

Dec

01

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

Dec

01

Media Statement on levetiracetam (KEPPRA® and KEPPRA XR®) and DRESS